Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cells

Published:2013-06 Issue:6 Volume:49 Page:591-597
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Hsu Heng-Wei,Gridley Daila S.,Kim Paul D.,Hu Shaoyan,de Necochea-Campion Rosalia,Ferris Robert L.,Chen Chien-Shing,Mirshahidi Saied

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference43 articles.

1. Cancer statistics;Jemal;CA: A Cancer J Clin,2009

2. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;New Engl J Med,2004

3. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;New Eng J Med,2004

4. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma;de Castro;Eur Arch Oto-Rhino-L,2007

5. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma;Yin;Head Neck,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy for head and neck cancer: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-01-16

2. Linifanib induces apoptosis in human ovarian cancer cells via activation of FOXO3 and reactive oxygen species;Arabian Journal of Chemistry;2022-12

3. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer;Archives of Pharmacal Research;2022-08

4. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy;Cancers;2020-08-30

5. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth;BMC Cancer;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3